In line with its determination to stay ‘at the forefront of medical technology’, BeaconMedæs has launched what is dubs ‘the next generation’ of medical gas terminal units.
The company says the GEM B terminal units ‘not only look more modern’, but also incorporate an anti-microbial additive to help reduce cross-infection ‘for added patient safety’.
The company explained: “The antimicrobial additive kills bacterial cells in a number of ways. The additive binds to the cell wall of bacteria, disrupting growth. The ions interfere with enzyme production, stopping the cell from producing energy, while the additive also interrupts the cell’s DNA, preventing replication. Independent laboratory reports show a reduction of E-coli and MRSA greater than 99 per cent.”
A safety taggant enables users to verify that the unit includes the antimicrobial additive, ‘for complete peace of mind’.
“With the anti-microbial additive improving patient safety, our GEM B terminal units meet needs even beyond what we provided with our trusted GEM 10 Installations,” said Andy Tudor, Atlas Copco Medical UK product development manager.
The new GEM B terminal unit features a ‘modernised’ trim plate that removes dust traps, decreasing the risk of cross infection. The fixing screws can be accessed from the front on, cutting exchange time by 15 minutes, and providing for quick and simple routine maintenance.
All GEM B terminal units are easily retrofitted onto existing GEM 10 installations.
